Skip to main content
DNA Labs India

SRGAP1 Gene Thyroid cancer type 2, nonmedullary, susceptibility to NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

SRGAP1 Gene Thyroid cancer type 2, nonmedullary, susceptibility to NGS Genetic Test

Short Name: SRGAP1 NGS Thyroid Cancer Susceptibility

Also known as: SRGAP1 Gene Mutation Test, Thyroid Cancer Susceptibility NGS Panel, NMTC2 Genetic Screening

SRGAP1 Gene Thyroid cancer type 2, nonmedullary, susceptibility to NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in Results are usually delivered within 3 to 4 weeks after the sample reaches the laboratory. You will be notified via email or SMS when the report is ready.. Free home collection in 300+ cities across India.

NGS Genetic Test🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of this NGS genetic test is to detect mutations in the SRGAP1 gene that are associated with an increased susceptibility to nonmedullary thyroid cancer type 2 (NMTC2). By identifying these genetic variants, the test helps in early diagnosis, risk assessment, and guiding clinical management. It also aids in genetic counseling for family members who may be at risk.

Test Code
6024
CPT Code
81479
ICD Code
Z15.09
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
Results are usually delivered within 3 to 4 weeks after the sample reaches the laboratory. You will be notified via email or SMS when the report is ready.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No special preparation required. However, a genetic counseling session is recommended before the test to discuss implications. Please inform your doctor about any medications or supplements you are taking.

Method: Venipuncture or Fingerstick

Step 2

Laboratory Analysis

Blood sample will be collected by a trained phlebotomist. For FTA card, a simple fingerstick is sufficient. The procedure is quick and minimally invasive.

Step 3

Report Delivery

No specific precautions. You can resume normal activities immediately. The sample will be sent to the laboratory for analysis.

Timeline: Results are usually delivered within 3 to 4 weeks after the sample reaches the laboratory. You will be notified via email or SMS when the report is ready.

Patient Instructions

1
Before the Test:Before undergoing the SRGAP1 gene test, you will have a genetic counseling session to discuss the purpose, risks, benefits, and potential outcomes. This helps you make an informed decision.
2
During the Test:During the test, a blood sample is drawn from your arm or a fingerstick for FTA card. The procedure is quick and causes minimal discomfort.
3
After the Test:After the test, you can resume normal activities. Results are typically available in 3-4 weeks. You will receive a detailed report, and a genetic counselor will explain the findings and their implications.

About This Test

Who Should Get This Test

The purpose of this NGS genetic test is to detect mutations in the SRGAP1 gene that are associated with an increased susceptibility to nonmedullary thyroid cancer type 2 (NMTC2). By identifying these genetic variants, the test helps in early diagnosis, risk assessment, and guiding clinical management. It also aids in genetic counseling for family members who may be at risk.

How to Prepare

  • Ensure the sample is collected in the provided EDTA tube or on the FTA card.
  • Label the sample with your name, date of birth, and collection date.
  • If using FTA card, allow the blood spot to air dry completely before sealing.
  • Store the sample at room temperature (15-30°C) until shipment.
  • Avoid hemolysis or clotting of blood sample.

Doctor's Notes

Reviewed by — MBBS, MD (General Medicine) · Reg. No. 8052

"Genetic testing for SRGAP1 mutations is crucial for early risk assessment in families with nonmedullary thyroid cancer. NGS provides comprehensive analysis to guide surveillance and preventive strategies."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml blood or 1 drop on FTA card
ContainerEDTA tube or FTA card
Collection MethodVenipuncture or Fingerstick

Sample Stability

Blood in EDTA tube
Blood in EDTA tube
FTA card
Sample Rejection Criteria:
  • Hemolyzed or clotted blood sample
  • Insufficient sample volume
  • Sample received after prolonged transit time (>7 days)
  • Improper labeling or missing patient information
  • Sample contaminated or leaked

Understanding Your Results

The interpretation of the SRGAP1 gene test is based on the presence or absence of pathogenic variants. Results are classified according to the American College of Medical Genetics and Genomics (ACMG) guidelines.
📊

Negative

No pathogenic variants detected in the SRGAP1 gene. This reduces the likelihood of hereditary NMTC2 due to SRGAP1, but does not exclude other genetic causes.

📊

Positive

A pathogenic or likely pathogenic variant was identified. This indicates an increased risk for developing nonmedullary thyroid cancer type 2. Genetic counseling and enhanced surveillance are recommended.

📊

Variant of Uncertain Significance (VUS)

A genetic variant was found, but its clinical significance is not yet known. Further testing of family members may help clarify the variant's role.

⚠️ When to Consult a Doctor:

If you have a family history of thyroid cancer, especially nonmedullary type, or if you have symptoms such as a neck lump, difficulty swallowing, or hoarseness, consult your doctor. A positive genetic test result should be discussed with an oncologist or genetic counselor to plan appropriate surveillance and preventive measures.

Limitations

  • This test only analyzes the SRGAP1 gene; other genes associated with thyroid cancer are not covered.
  • Variant of uncertain significance (VUS) may be reported; further family studies may be needed.
  • This test does not detect large deletions/duplications or epigenetic changes.
  • Negative result does not rule out hereditary cancer risk due to other genes.
  • Clinical correlation is essential; genetic testing is not a substitute for medical evaluation.

Risks & Considerations

  • No significant physical risks associated with blood draw
  • Possible bruising or infection at the puncture site (rare)
  • Psychological impact of learning genetic risk
  • Potential for incidental findings (unrelated genetic variants)

Interfering Factors

  • Contamination of sample with foreign DNA
  • Insufficient DNA quantity or quality
  • Presence of hematologic malignancies causing clonal hematopoiesis
  • Recent blood transfusion (within 2 weeks)
  • Bone marrow transplantation

Compare With Similar Tests

TestSRGAP1 Gene Thyroid cancer type 2, nonmedullary, susceptibility to NGS Genetic TestRET Gene Mutation AnalysisComprehensive Thyroid Cancer Panel
ComparisonSRGAP1 Gene Thyroid cancer type 2, nonmedullary, susceptibility to NGS Genetic Test

Frequently Asked Questions

What is the SRGAP1 gene?
The SRGAP1 gene (SLIT-ROBO Rho GTPase-activating protein 1) is located on chromosome 1 and encodes a protein involved in neuronal development and cell migration. Mutations in this gene have been associated with increased susceptibility to nonmedullary thyroid cancer type 2.
What is nonmedullary thyroid cancer type 2 (NMTC2)?
NMTC2 is a hereditary subtype of thyroid cancer that arises from follicular cells. It accounts for approximately 5-10% of all thyroid cancer cases and is linked to mutations in genes like SRGAP1.
Who should consider this genetic test?
Individuals with a family history of nonmedullary thyroid cancer, especially type 2, those with early-onset thyroid cancer, or those with multiple affected family members should consider this test. It is also useful for individuals with clinical suspicion of hereditary cancer.
What is the cost of the SRGAP1 gene NGS test?
The test costs INR 20,000. This includes genetic counseling, NGS sequencing, bioinformatics analysis, and a comprehensive clinical report. We also provide raw data files (FASTQ, VCF) for transparency.
What sample is required for the test?
The test can be performed on blood (2-3 ml in EDTA tube) or extracted DNA. Alternatively, a single drop of blood on an FTA card is sufficient. Home sample collection is available free of charge.
How long does it take to get results?
Results are typically available within 3 to 4 weeks after the sample reaches the laboratory. You will receive an email or WhatsApp notification when the report is ready.
What does a positive result mean?
A positive result indicates the presence of a pathogenic or likely pathogenic variant in the SRGAP1 gene, which increases your risk for developing nonmedullary thyroid cancer type 2. It is recommended to discuss the result with an oncologist or genetic counselor for personalized surveillance and management.
What does a negative result mean?
A negative result means no pathogenic variants were detected in the SRGAP1 gene. However, it does not completely rule out hereditary thyroid cancer, as other genes may be involved. Your doctor may recommend additional testing if clinically indicated.
What is a variant of uncertain significance (VUS)?
A VUS is a genetic variant whose impact on health is not yet known. Further testing of family members may help clarify its significance. Your genetic counselor will guide you on the next steps.
Is genetic counseling included in the test?
Yes, a genetic counseling session is included to draw a pedigree chart and discuss the implications of the test. This is essential for understanding your risk and making informed decisions.
Can this test be done during pregnancy?
Yes, the test can be performed during pregnancy as it only requires a blood sample. However, it is important to discuss the implications with your obstetrician and genetic counselor before proceeding.
Does DNA Labs India provide raw data files?
Yes, DNA Labs India is the only lab that provides raw data files (FASTQ, VCF) along with the clinical report. This ensures transparency and allows for further analysis if needed.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.